OSTEOARTHRITIS
Extracorporeal shockwave therapy efficacious for pain and function in knee OA treatment
This report has been verified
by one or more authors of the
original publication.
J Surg Res. 2013 Dec;185(2):661-6. doi: 10.1016/j.jss.2013.07.004. Epub 2013 Jul 30
70 patients with knee osteoarthritis (OA) were randomized to investigate the effect of extracorporeal shockwave therapy on pain and function associated with OA. Participants were allocated to receive 4 weekly administrations of either ESWT or placebo treatment, and were followed-up up at 12 weeks. The results indicated that the ESWT group experienced significantly greater improvements in pain and function, and had better perception of OA severity at 12 weeks.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
